Allelic variation in the serotonin transporter (5HTT) gene contributes to idiopathic pulmonary hypertension in children
- 28 June 2005
- journal article
- clinical trial
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 334 (2) , 376-379
- https://doi.org/10.1016/j.bbrc.2005.06.107
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (DK56063, HD39952)
- March of Dimes Foundation (6-FY99-441)
This publication has 14 references indexed in Scilit:
- Overexpression of the 5-Hydroxytryptamine Transporter GeneCirculation, 2004
- Serotonin Transporter Inhibitors Protect against Hypoxic Pulmonary HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 2003
- Functional Heterogeneity of Bone Morphogenetic Protein Receptor-II Mutants Found in Patients with Primary Pulmonary HypertensionMolecular Biology of the Cell, 2002
- Functional analysis of bone morphogenetic protein type II receptor mutations underlying primary pulmonary hypertensionHuman Molecular Genetics, 2002
- Is the serotonin transporter involved in the pathogenesis of pulmonary hypertension?Journal of Laboratory and Clinical Medicine, 2002
- Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertensionJournal of Clinical Investigation, 2001
- BMPR2 Haploinsufficiency as the Inherited Molecular Mechanism for Primary Pulmonary HypertensionAmerican Journal of Human Genetics, 2001
- Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta familyJournal of Medical Genetics, 2000
- Heterozygous germline mutations in BMPR2, encoding a TGF-β receptor, cause familial primary pulmonary hypertensionNature Genetics, 2000
- Primary Pulmonary HypertensionNew England Journal of Medicine, 1997